RxDoctor Payments Data

Parin Patel, MD

Clinical Cardiac Electrophysiology · Indianapolis, INNPI 1497917074

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (34.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Boston Scientific at 34.1% of the total. Reporting peaked in 2023 at $11,421 and has fallen 68.4% since, to $3,613 in 2025.

$38,678in general payments, 2019–2025

Across 177 payments — averaging $218.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$13K
  • Medtronic$7K
  • Medical Device Business Services, Inc.$7K
  • Abbott$6K
  • Biosense Webster, Inc.$2K
  • Cvrx, Inc.$2K
  • plus $2K from 11 others
$268,311in research payments, 2019–2025

Across 55 payments — averaging $4878.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$266K
  • Biosense Webster, Inc.$2K

What the payments were for

  • Consulting fees$13,42535%
  • Speaking & faculty fees$8,00021%
  • Travel & lodging$6,68617%
  • Food & beverage$10,56827%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,678 in reported general payments places this provider in the 70th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

See all clinical cardiac electrophysiology providers in Indiana

Medicare billing

Part B allowed, 2024
$283,683
Medicare patients
650
Services billed
3,635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban315$364,992
XareltoRivaroxaban46$50,963
EntrestoSacubitril/Valsartan18$18,989
Dofetilide29$8,385
Amiodarone Hcl151$6,631
Propafenone Hcl ErPropafenone Hcl15$4,507
Mexiletine Hcl22$3,340
Metoprolol Succinate255$3,255
Dabigatran EtexilateDabigatran Etexilate Mesylate16$2,682
Flecainide Acetate59$2,623
Diltiazem 24hr Er (Cd)Diltiazem Hcl71$1,398
SotalolSotalol Hcl62$1,258
Propafenone Hcl18$840
Carvedilol73$683
ClopidogrelClopidogrel Bisulfate77$604

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →